Cordlife Group

Cordlife is a consumer healthcare company focused on the well-being of mothers and children, operating primarily in the Asia Pacific region. The company provides private cord blood banking services and has processing and storage facilities in six key markets: Singapore, Hong Kong, Malaysia, India, Indonesia, and the Philippines. Cordlife operates through two main segments: the Banking segment, which includes services for cord blood, cord lining, and cord tissue, and the Diagnostics segment, which offers non-invasive screening services. This includes Metascreen, a metabolic screening test for newborns, non-invasive prenatal testing, and Eyescreen, a pediatric eye screening service. Through these offerings, Cordlife aims to support families in safeguarding their health from early life stages.

Yiu Pang Fai

Group CEO

2 past transactions

HealthBaby Biotech

Acquisition in 2018
HealthBaby Biotech (Hong Kong) Co., Ltd. operates as a cord blood bank. The company was founded in 2005 and is based in Shatin, Hong Kong. As of January 2, 2018, HealthBaby Biotech (Hong Kong) Co., Ltd. operates as a subsidiary of Cordlife Group Limited.

Stemlife Berhad

Acquisition in 2015
StemLife Berhad is a company based in Kuala Lumpur, Malaysia, specializing in stem cell banking services for newborns. Founded in 2001, it provides comprehensive services that include the collection, testing, processing, and preservation of umbilical cord blood stem cells, umbilical cord tissue, Wharton Jelly, and peripheral blood stem cells. The company also offers stem cell therapy and consultancy services, focusing on the therapeutic applications of these stem cells for conditions such as pediatric leukemia, blood-related disorders, heart disease, and sports injuries. Additionally, StemLife Berhad is involved in property investments and is a subsidiary of Cordlife Group Limited.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.